ArticleMolecular pharmaceutics2015

Simultaneously targeting tissue transglutaminase and kidney type glutaminase sensitizes cancer cells to acid toxicity and offers new opportunities for therapeutic intervention.

William P Katt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.